131 related articles for article (PubMed ID: 6394042)
1. Autologous bone marrow transplantation contributes to haemopoietic recovery in children with solid tumours treated with high dose melphalan.
Kingston JE; Malpas JS; Stiller CA; Pritchard J; McElwain TJ
Br J Haematol; 1984 Dec; 58(4):589-95. PubMed ID: 6394042
[TBL] [Abstract][Full Text] [Related]
2. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
[TBL] [Abstract][Full Text] [Related]
3. Busulphan and melphalan prior to autologous bone marrow transplantation.
Srivastava A; Bradstock KF; Szer J; de Bortoli L; Gottlieb DJ
Bone Marrow Transplant; 1993 Oct; 12(4):323-9. PubMed ID: 8275031
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic recovery following autologous bone marrow transplantation: role of cryopreservation, number of cells infused and nature of high-dose chemotherapy.
Hartmann O; Beaujean F; Bayet S; Pico JL; Tournade MF; Lemerle ; Parmentier C
Eur J Cancer Clin Oncol; 1985 Jan; 21(1):53-60. PubMed ID: 3882431
[TBL] [Abstract][Full Text] [Related]
5. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.
McElwain TJ; Hedley DW; Burton G; Clink HM; Gordon MY; Jarman M; Juttner CA; Millar JL; Milsted RA; Prentice G; Smith IE; Spence D; Woods M
Br J Cancer; 1979 Jul; 40(1):72-80. PubMed ID: 383125
[TBL] [Abstract][Full Text] [Related]
6. High-dose melphalan with autologous bone marrow rescue for the treatment of advanced adult solid tumors.
Maraninchi D; Abecasis M; Gastaut JA; Herve P; Sebahoun G; Flesch M; Blanc AP; Carcassonne Y
Cancer Treat Rep; 1984 Mar; 68(3):471-4. PubMed ID: 6367977
[TBL] [Abstract][Full Text] [Related]
7. Double-intensive therapy in high-risk multiple myeloma.
Harousseau JL; Milpied N; Laporte JP; Collombat P; Facon T; Tigaud JD; Casassus P; Guilhot F; Ifrah N; Gandhour C
Blood; 1992 Jun; 79(11):2827-33. PubMed ID: 1350228
[TBL] [Abstract][Full Text] [Related]
8. High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma.
McElwain TJ; Hedley DW; Gordon MY; Jarman M; Millar JL; Pritchard J
Exp Hematol; 1979; 7 Suppl 5():360-71. PubMed ID: 400698
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
[TBL] [Abstract][Full Text] [Related]
10. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.
Bonetti F; Zecca M; Pession A; Messina C; Montagna D; Lanino E; Fagioli F; Santoro N; Prete A; Cesaro S; Rondelli R; Giorgiani G; De Stefano P; Locatelli F
J Clin Oncol; 1999 Dec; 17(12):3729-35. PubMed ID: 10577844
[TBL] [Abstract][Full Text] [Related]
11. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation.
Lazarus HM; Herzig RH; Wolff SN; Phillips GL; Spitzer TR; Fay JW; Herzig GP
Cancer Treat Rep; 1985 May; 69(5):473-7. PubMed ID: 3891085
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced neuroblastoma with high-dose melphalan and autologous bone marrow transplantation.
Hartmann O; Kalifa C; Benhamou E; Patte C; Flamant F; Jullien C; Beaujean F; Lemerle J
Cancer Chemother Pharmacol; 1986; 16(2):165-9. PubMed ID: 3512113
[TBL] [Abstract][Full Text] [Related]
15. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
Pritchard J; McElwain TJ; Graham-Pole J
Br J Cancer; 1982 Jan; 45(1):86-94. PubMed ID: 7037033
[TBL] [Abstract][Full Text] [Related]
16. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
17. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G
Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma.
Leff RS; Thompson JM; Johnson DB; Mosley KR; Daly MB; Knight WA; Ruxer RL; Messerschmidt GL
J Clin Oncol; 1986 Nov; 4(11):1586-91. PubMed ID: 3534154
[TBL] [Abstract][Full Text] [Related]
19. Recovery of blood and bone marrow stem cells following intense chemotherapy and autologous bone marrow transplantation.
Thomas MR; Robinson WA; Mughal TI; Morton N; Glode LM
Oncology; 1986; 43(5):273-7. PubMed ID: 3531952
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Demuynck HM; Link H; Zander A; Barge A
Lancet; 1996 Feb; 347(8998):353-7. PubMed ID: 8598700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
